PRESS RELEASE published on 02/28/2023 at 14:30, 3 years 6 months ago FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication in the US
PRESS RELEASE published on 02/23/2023 at 14:30, 3 years 6 months ago Jaguar Health Receives Notice of Allowance for U.S. Patent for Lead FDA Approved Drug Crofelemer
PRESS RELEASE published on 02/21/2023 at 14:30, 3 years 6 months ago Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 02/09/2023 at 14:30, 3 years 7 months ago Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
PRESS RELEASE published on 02/08/2023 at 14:30, 3 years 7 months ago Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
PRESS RELEASE published on 02/01/2023 at 15:45, 3 years 7 months ago Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
PRESS RELEASE published on 02/01/2023 at 14:30, 3 years 7 months ago Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
PRESS RELEASE published on 01/30/2023 at 14:30, 3 years 7 months ago Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
PRESS RELEASE published on 01/27/2023 at 22:15, 3 years 7 months ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 01/26/2023 at 14:30, 3 years 7 months ago Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
Published on 09/16/2026 at 15:00, 1 hour 42 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 2 hours 42 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/16/2026 at 13:30, 3 hours 12 minutes ago Sterling Extends Core MEPS Copper Zone to 700m; Intersects 200m of 0.53% CuEq Including 102m of 0.81% CuEq
Published on 09/16/2026 at 13:23, 3 hours 19 minutes ago SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 13:15, 3 hours 27 minutes ago Impauer Technologies Announces Launch Of New Corporate Website And Provides OTC Symbol Update
Published on 09/16/2026 at 16:35, 6 minutes ago Piramal Pharma Solutions Advances Sustainability Efforts with Solar Power Plant Addition at Morpeth, UK Site
Published on 09/16/2026 at 15:50, 51 minutes ago Huawei's latest report proposes 10 key directions to Intelligent World 2035
Published on 09/16/2026 at 15:50, 51 minutes ago FP Markets wins three awards at the Global Forex Awards 2026
Published on 09/16/2026 at 15:36, 1 hour 6 minutes ago Custodian Property Income REIT plc: Share Buyback
Published on 09/16/2026 at 15:04, 1 hour 37 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/16/2026 at 07:00, 9 hours 42 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 22 hours 42 minutes ago Report on the Combined General Meeting of the 10th of September 2026
Published on 09/15/2026 at 17:45, 22 hours 57 minutes ago EURAZEO COMPLETES THE ACQUISITION OF NETCO GROUP
Published on 09/15/2026 at 17:43, 22 hours 59 minutes ago Aéroports de Paris S.A - August 2026 traffic figures
Published on 09/15/2026 at 17:01, 23 hours 40 minutes ago Number of shares and voting rights - August 2026 (In French only)
